(Q40499853)

21 September 2017

Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages (English)

1 reference

21 September 2017

0 references

0 references

0 references

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Peter Ponsaerts

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Debbie Le Blon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Disha Shah

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sven Hendrix

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Zwi N Berneman

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Annemie Van der Linden

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Caroline Guglielmetti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Eva Santermans

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Angelica Salas-Perdomo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jasmijn Daans

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Nathalie De Vocht

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Chloé Hoornaert

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jelle Praet

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jurgen Peerlings

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Firat Kara

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Christian Bigot

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Zhenhua Mai

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Herman Goossens

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Marleen Verhoye

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Anna M Planas

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

29 September 2016

1 reference

21 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

2181-2200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

TREM2 regulates microglial cell activation in response to demyelination in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

The origin and cell lineage of microglia: new concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Repertoire of microglial and macrophage responses after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Quantitative and phenotypic analysis of mesenchymal stromal cell graft survival and recognition by microglia and astrocytes in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Alternatively activated microglia and macrophages in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Upscaling of lentiviral vector production by tangential flow filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Fate mapping analysis reveals that adult microglia derive from primitive macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Origin and differentiation of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Role of microglia in CNS autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Magnetization transfer in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Regional differences between grey and white matter in cuprizone induced demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

In vivo IL13-primed macrophages contribute to reduced alloantigen-specific T cell activation and prolong immunological survival of allogeneic mesenchymal stem cell implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Lentivirus technologies for modulation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Oncostatin M protects against demyelination by inducing a protective microglial phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

State-of-the-art gene-based therapies: the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Interleukin-4 and interleukin-13 signaling connections maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

21 January 2018

Physiology of microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

The cuprizone animal model: new insights into an old story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Inefficient clearance of myelin debris by microglia impairs remyelinating processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Adoptive transfer of M2 macrophages promotes locomotor recovery in adult rats after spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Pathological mechanisms in progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

The M1 and M2 paradigm of macrophage activation: time for reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Recent advances in lentiviral vector development and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

M-1/M-2 macrophages and the Th1/Th2 paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Gene expression in brain during cuprizone-induced demyelination and remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Cranial irradiation alters the brain's microenvironment and permits CCR2+ macrophage infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Macrophage activation and polarization: nomenclature and experimental guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Identification of a microglia phenotype supportive of remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Microglial M1/M2 polarization and metabolic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

The MT pool size ratio and the DTI radial diffusivity may reflect the myelination in shiverer and control mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Immune surveillance in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Microglia in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

TREM2 sustains microglial expansion during aging and response to demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Recent developments in imaging of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Cell Type-Associated Differences in Migration, Survival, and Immunogenicity following Grafting in CNS Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Early Inflammatory Responses Following Cell Grafting in the CNS Trigger Activation of the Subventricular Zone: A Proposed Model of Sequential Cellular Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Histological characterization and quantification of cellular events following neural and fibroblast(-like) stem cell grafting in healthy and demyelinated CNS tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Heterogeneity of CNS myeloid cells and their roles in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Microglial physiology: unique stimuli, specialized responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

The benefits and detriments of macrophages/microglia in models of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Quantitative evaluation of stem cell grafting in the central nervous system of mice by in vivo bioluminescence imaging and postmortem multicolor histological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Microglial recruitment, activation, and proliferation in response to primary demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Magnetization transfer MR imaging in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Role of glial cells in innate immunity and their role in CNS demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Stem cell-based therapies for cancer treatment: separating hope from hype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Microglia: gatekeepers of central nervous system immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

In vivo quantitative magnetization transfer imaging correlates with histology during de- and remyelination in cuprizone-treated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

MRI in the Diagnosis and Monitoring of Multiple Sclerosis: An Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Interleukin-13/Interleukin-4-induced oxidative stress contributes to death of prothrombinkringle-2 (pKr-2)-activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Interleukin-13 and -4 induce death of activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Neuronal Interleukin-4 as a Modulator of Microglial Pathways and Ischemic Brain Damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

Multicontrast MRI of remyelination in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

inferred from DOI database lookup

7 January 2021

based on heuristic

CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.23053

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/GLIA.23053

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27685637%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference